Full metadata record

DC Field Value Language
dc.contributor.authorYoo, HS-
dc.contributor.authorLee, JE-
dc.contributor.authorChung, H-
dc.contributor.authorKwon, IC-
dc.contributor.authorJeong, SY-
dc.date.accessioned2024-01-21T05:13:45Z-
dc.date.available2024-01-21T05:13:45Z-
dc.date.created2021-09-03-
dc.date.issued2005-03-02-
dc.identifier.issn0168-3659-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/136651-
dc.description.abstractA self-assembled nanoparticle was prepared using a hydrophobically modified glycol chitosan for gene delivery. A primary amine of glycol chitosan was modified with 5 beta-cholanic acid to prepare a hydrophobically modified glycol chitosan (HGC). The modified chitosan spontaneously formed DNA nanoparticles by a hydrophobic interaction between HGC and hydrophobized DNA. As the HGC content increased, the encapsulation efficiencies of DNA increased while the size of HGC nanoparticles decreased. Upon increasing HGC contents, HGC nanoparticle became less cytotoxic. The increased HGC contents also facilitated endocytic uptakes of HGC nanoparticles by COS-1 cells, which were confirmed by a confocal microscopy. The HGC nanoparticles showed increasing in vitro transfection efficiencies in the presence serum. In vivo results also showed that the HGC nanoparticles had superior transfection efficiencies to naked DNA and a commercialized transfection agent. The HGC nanoparticles composed of hydrophobized DNA and hydrophobically modified glycol chitosan played a significant role in enhancing transfection efficiencies in vitro as well as in vivo. (c) 2004 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectBEARING 5-BETA-CHOLANIC ACID-
dc.subjectTRANSFECTION EFFICIENCY-
dc.subjectDNA NANOPARTICLES-
dc.subjectCOMPLEX-
dc.subjectSYSTEM-
dc.titleSelf-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery-
dc.typeArticle-
dc.identifier.doi10.1016/j.jconrel.2004.11.033-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF CONTROLLED RELEASE, v.103, no.1, pp.235 - 243-
dc.citation.titleJOURNAL OF CONTROLLED RELEASE-
dc.citation.volume103-
dc.citation.number1-
dc.citation.startPage235-
dc.citation.endPage243-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000227546800021-
dc.identifier.scopusid2-s2.0-13844265668-
dc.relation.journalWebOfScienceCategoryChemistry, Multidisciplinary-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusBEARING 5-BETA-CHOLANIC ACID-
dc.subject.keywordPlusTRANSFECTION EFFICIENCY-
dc.subject.keywordPlusDNA NANOPARTICLES-
dc.subject.keywordPlusCOMPLEX-
dc.subject.keywordPlusSYSTEM-
dc.subject.keywordAuthorgene delivery-
dc.subject.keywordAuthorchitosan-
dc.subject.keywordAuthorself-assembled-
dc.subject.keywordAuthorin vivo transfection-
Appears in Collections:
KIST Article > 2005
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE